Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
Wang F, Habtemariam A, van der Geer EP, Fernández R, Melchart M, Deeth RJ, Aird R, Guichard S, Fabbiani FP, Lozano-Casal P, Oswald ID, Jodrell DI, Parsons S, Sadler PJ. Wang F, et al. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18269-74. doi: 10.1073/pnas.0505798102. Epub 2005 Dec 13. Proc Natl Acad Sci U S A. 2005. PMID: 16352726 Free PMC article.
Inhibition of cancer cell growth by ruthenium(II) arene complexes.
Morris RE, Aird RE, Murdoch Pdel S, Chen H, Cummings J, Hughes ND, Parsons S, Parkin A, Boyd G, Jodrell DI, Sadler PJ. Morris RE, et al. Among authors: aird re. J Med Chem. 2001 Oct 25;44(22):3616-21. doi: 10.1021/jm010051m. J Med Chem. 2001. PMID: 11606126
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
Guichard SM, Else R, Reid E, Zeitlin B, Aird R, Muir M, Dodds M, Fiebig H, Sadler PJ, Jodrell DI. Guichard SM, et al. Biochem Pharmacol. 2006 Feb 14;71(4):408-15. doi: 10.1016/j.bcp.2005.10.053. Epub 2005 Dec 19. Biochem Pharmacol. 2006. PMID: 16360645
Novel ruthenium(II) organo-metallic compounds are active in ovarian cancer models [Aird RE, Cummings J, Ritchie AA, Muir M, Morris RE, Chen H, et al. In vitro and in vivo activity and cross resistance profiles of novel ruthenium(II) organometallic arene compl …
Novel ruthenium(II) organo-metallic compounds are active in ovarian cancer models [Aird RE, Cummings J, Ritchie AA, Muir M, Mo …
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL, Schornagel QC, Tente R, Macpherson JS, Aird RE, Guichard S, Habtemariam A, Sadler P, Jodrell DI. Hayward RL, et al. Among authors: aird re. Cancer Chemother Pharmacol. 2005 Jun;55(6):577-83. doi: 10.1007/s00280-004-0932-9. Epub 2005 Feb 22. Cancer Chemother Pharmacol. 2005. PMID: 15726367
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.
Brown ER, Charles KA, Hoare SA, Rye RL, Jodrell DI, Aird RE, Vora R, Prabhakar U, Nakada M, Corringham RE, DeWitte M, Sturgeon C, Propper D, Balkwill FR, Smyth JF. Brown ER, et al. Among authors: aird re. Ann Oncol. 2008 Jul;19(7):1340-1346. doi: 10.1093/annonc/mdn054. Epub 2008 Mar 5. Ann Oncol. 2008. PMID: 18325912 Free article. Clinical Trial.
18 results